(Q34044918)

English

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort (English)

1 reference

Europe PubMed Central

30 July 2017

0 references

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

John D Reveille

4

object named as

J D Reveille

1 reference

Europe PubMed Central

30 July 2017

Graciela S Alarcón

5

object named as

G S Alarcón

1 reference

Europe PubMed Central

30 July 2017

author name string

S Durán-Barragán

1

1 reference

Europe PubMed Central

30 July 2017

G McGwin

2

1 reference

Europe PubMed Central

30 July 2017

L M Vilá

3

1 reference

Europe PubMed Central

30 July 2017

LUMINA (LIX): a multiethnic US cohort

6

1 reference

Europe PubMed Central

30 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

29 May 2008

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

47

1 reference

Europe PubMed Central

30 July 2017

7

1 reference

Europe PubMed Central

30 July 2017

1093-1096

1 reference

Europe PubMed Central

30 July 2017

Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Preventing microalbuminuria in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Should we use a case-crossover design?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN208

21 January 2018

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Constitutive production of angiotensin converting enzyme from rheumatoid nodule cells under serum free conditions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Production of angiotensin converting enzyme by rheumatoid synovial membrane.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

5 July 2018

Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients.

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN208

21 January 2018

Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN208

21 January 2018

Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2916239

28 October 2018

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: Measures of overall disease activity

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEN208

21 January 2018

The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/18511474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should low-dose aspirin also be a background therapy for all patients with systemic lupus erythematosus (SLE)?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18511474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril prevents experimental autoimmune myocarditis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18511474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Captopril: a new treatment for rheumatoid arthritis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18511474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of in vitro granulocytopoiesis by captopril and penicillamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18511474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18511474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/RHEUMATOLOGY/KEN208

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34044918&oldid=1752696339"